Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.

Parasitology research - 1 Sept 2007

Mlambo Godfree, Sullivan David, Mutambu Susan L, Soko White, Mbedzi Joel, Chivenga James, Gemperli Armin, Kumar Nirbhay

Abstract excerpt

Chloroquine has been the first line drug of treatment for malaria in Zimbabwe until a recent adoption of an interim policy to treat using a combination of chloroquine (CQ) and sulfadoxine/pyrimethamine (SP). We examined the prevalence of parasites with mutations associated with resistance to the drug combination in three areas that have been previously described to differ in malaria endemicity. Our results show...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Chloroquine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Protozoan

Share to Drug Combinations

Share to Malaria, Falciparum

Share to Pyrimethamine

Share to Sulfadoxine

Share to Zimbabwe

Source

Identifiers

PMID: 17546463
DOI: 10.1007/s00436-007-0597-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.PMID 17546463Read ↗

High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.Semantic proximity Read ↗

Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genesSemantic proximity Read ↗

Molecular markers of chloroquine resistance in Plasmodium falciparum in Sri Lanka: frequency before revision of the antimalarial drug policy.Semantic proximity Read ↗

Molecular Surveillance of malaria in Nigeria reveals expansion of chloroquine-sensitive infectionsSemantic proximity Read ↗

Molecular markers in epidemiological monitoring of the spread of resistance to antimalarials: a review.Semantic proximity Read ↗

Frequencies of molecular markers of drug resistance in the context of two different Seasonal Malaria Chemoprevention (SMC) treatment regimens in the Koulikoro health district, Mali.Semantic proximity Read ↗

Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.Semantic proximity Read ↗

Molecular Diagnosis of Resistance to Antimalarial Drugs during Epidemics and in War ZonesSemantic proximity Read ↗

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.Semantic proximity Read ↗

Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in MozambiqueSemantic proximity Read ↗

Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.Semantic proximity Read ↗

Plasmodium falciparum Genomic Surveillance Reveals a Diversity of Kelch 13 Mutations in ZambiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.